货号：UP257841457
| 产品信息 | |
| 产品名称： | WEHI-345 analog |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1354825-62-9 |
| 分子式： | C23H25N7O |
| 分子量： | 415.49 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP257841457) |
| 沸点： | - |
| 储存： | (UP257841457) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
Syk
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
Ros1
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
TAM Receptor
Tariquidar
UP661657182206873-63-4
inS3-54-A18
UP792358716328998-53-4
SMP-114
UP946045678215174-50-8
YHO-13351
UP3253917191346753-00-1
WAY-316606
UP277993726915759-45-4
FTI-277
UP853241633170006-73-2
KN-93 Phosphate
UP3982499211188890-41-6
(R)-(+)-Etomoxir Sodium
UP758484760828934-41-4
Gastrodenol
UP99048433157644-54-9
(4-Bromothiophen-2-yl)methanamine hydrochloride
UP5033482681171697-10-1
Ropivacaine Hydrochloride Monohydrate
UP447685216132112-35-7
(E)-1-Chloro-4-(2-nitrovinyl)benzene
UP3365115755153-70-8
cis-(Z)-Flupentixol dihydrochloride
UP65342001151529-01-2
Pantoprazole
UP694346555102625-70-7
1-Naphthyl PP1 hydrochloride
UP112522794956025-47-1
Elacridar
UP179646260143664-11-3
ML348
UP484645965899713-86-1
BLU9931
UP9045687431538604-68-0
Dapagliflozin
UP558666293461432-26-8
Escitalopram oxalate
UP808815923219861-08-2
CP21R7
UP136611907125314-13-8
Sotrastaurin
UP663347646425637-18-9
AS-605240
UP647596565648450-29-7
4'-Hydroxy-4-biphenylcarbonitrile
UP89103790019812-93-2
GDC-0941
UP786860338957054-30-7
Pyridostigmine Bromide
UP301431077101-26-8
GSK1059615
UP819137229958852-01-2
(4AS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4
UP633154417852821-06-8
Metoclopramide
UP662471112364-62-5
AZD1080
UP973692041612487-72-6
(S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid
UP344198198402958-96-7
tert-Butyl (5-(tributylstannyl)thiazol-2-yl)carbamate
UP769606568243972-26-1
Rabeprazole sodium
UP240532939117976-90-6
CGP 37849
UP295801418127910-31-0
TG 100801
UP664638334867331-82-6
HG-9-91-01
UP1436909411456858-58-4
2-Butyl-4-chloro-5-formylimidazole
UP71816475983857-96-9
GNE-317
UP9701730481394076-92-6
Fluphenazine dihydrochloride
UP422364746146-56-5
MK2-IN-1 hydrochloride
UP3276039391314118-94-9
Chelerythrine Chloride
UP2404076103895-92-9
XL388
UP1259258721251156-08-7
Berbamine dihydrochloride
UP1150887796078-17-7
SPK-601
UP5930249541096687-52-3
BTB06584
UP784651461219793-45-0
Isobutyrimidamide hydrochloride
UP50648067822007-68-7
(24S)-24,25-Dihydroxyvitamin D3
UP85677293355700-58-8
Jervine
UP759780941469-59-0
Fluoxetine
UP83036546254910-89-3
1-Fluoronaphthalene
UP635088859321-38-0
Edrophonium chloride
UP195173369116-38-1
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine
UP665404841132335-44-5
Darapladib
UP311560677356057-34-6
PQ401
UP271510203196868-63-0
AZD8055
UP6061108411009298-09-2
Lemonol
UP826422473106-24-1
2,5-Bis(2-ethylhexyl)-3,6-bis(5-(trimethylstannyl)thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione
UP1154984151392422-47-7
AZD2858
UP171971373486424-20-8
Everolimus
UP241583572159351-69-6
Oglufanide
UP89219284838101-59-6
LY2940680
UP1496354041258861-20-9
4,7-Bis(5-(trimethylstannyl)thiophen-2-yl)benzo[c][1,2,5]thiadiazole
UP4155422871025451-57-3
5-Chlorothiophene-2-carboximidamide hydrochloride
UP410007788202336-16-1
CU-CPT17e
UP3169974612109805-75-4
Azaphen
UP64027438324853-80-3
Salirasib
UP774914570162520-00-5
(4S,5S)-Dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
UP51301749737031-30-4
IM-12
UP3168325421129669-05-1
20-Deoxyingenol 3-angelate
UP57625924975567-38-3
CAY10650
UP7251844961233706-88-1
LY2090314
UP776296325603288-22-8
CaMKII-IN-1
UP5310921671208123-85-6
(2R)-1-[(1R)-1-[Bis(3,5-dimethylphenyl)phosphino]ethyl]-2-(diphenylphosphino)ferrocene
UP631440158184095-69-0
3',4',5',6'-Tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one
UP8056368422103-64-2
Esomeprazole Magnesium
UP6941548651198768-91-0
BMS-817378
UP4252399261174161-69-3
GSK2334470
UP6574286371227911-45-6
WEHI-345 analog
UP2578414571354825-62-9